BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23147884)

  • 21. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
    Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
    Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American cutaneous leishmaniasis.
    Freeman K
    J R Army Med Corps; 1983 Oct; 129(3):167-73. PubMed ID: 6319690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis.
    Karimbil SK; Kumari S; Celine MI; Joy A
    Int J Dermatol; 2010 Apr; 49(4):426-9. PubMed ID: 20465699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous leishmaniasis.
    Bailey MS; Lockwood DN
    Clin Dermatol; 2007; 25(2):203-11. PubMed ID: 17350500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First report of mucosal tissue localisation of leishmaniasis in Sri Lanka.
    Rajapaksa US; Ihalamulla RL; Karunaweera ND
    Ceylon Med J; 2005 Jun; 50(2):90-1. PubMed ID: 16114778
    [No Abstract]   [Full Text] [Related]  

  • 27. Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases.
    Faucher B; Pomares C; Fourcade S; Benyamine A; Marty P; Pratlong L; Faraut F; Mary C; Piarroux R; Dedet JP; Pratlong F
    J Infect; 2011 Jul; 63(1):76-82. PubMed ID: 21658772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmaniasis with oral mucosa involvement.
    Pellicioli AC; Martins MA; Sant'ana Filho M; Rados PV; Martins MD
    Gerodontology; 2012 Jun; 29(2):e1168-71. PubMed ID: 22612832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milia and cutaneous leishmaniasis.
    Del Giudice P
    Br J Dermatol; 2007 May; 156(5):1088. PubMed ID: 17381448
    [No Abstract]   [Full Text] [Related]  

  • 30. Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases.
    Mahmoud AA; Warren KS
    J Infect Dis; 1977 Jul; 136(1):160-3. PubMed ID: 196028
    [No Abstract]   [Full Text] [Related]  

  • 31. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presentation of leishmaniasis (Leishmania infantum) in the skin of a patient with severe atopic dermatitis.
    Kerr A; Dawe RS; Nathwani D; Evans AT; Ferguson J
    Br J Dermatol; 2009 Jul; 161(1):202-3. PubMed ID: 19438451
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leishmaniasis].
    Kemp M; Theander TG
    Ugeskr Laeger; 2000 Nov; 162(46):6203-7. PubMed ID: 11107967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of visceral leishmaniasis in Finnish-type congenital nephrotic syndrome.
    Grech V; Vella C; Parascandolo R
    Pediatr Nephrol; 2000 May; 14(5):410-1. PubMed ID: 10805470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of mucocutaneous leishmaniasis in Saudi Arabia caused by Leishmania major and its response to treatment.
    Al-Gindan Y; Omer AH; A-Humaidan Y; Peters W; Evans DA
    Clin Exp Dermatol; 1983 Mar; 8(2):185-8. PubMed ID: 6303652
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S; Malakar S
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya.
    Rashid JR; Chunge CN; Oster CN; Wasunna KM; Muigai R; Gachihi GS
    East Afr Med J; 1986 May; 63(5):365-71. PubMed ID: 3017678
    [No Abstract]   [Full Text] [Related]  

  • 40. New approaches from nanomedicine for treating leishmaniasis.
    Gutiérrez V; Seabra AB; Reguera RM; Khandare J; Calderón M
    Chem Soc Rev; 2016 Jan; 45(1):152-68. PubMed ID: 26487097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.